Skip to main content

Table 1 Participant demographics and baseline characteristics in Study 1 and Study 2

From: Comparison of two biosimilarity studies of FKB327 with the adalimumab reference product: randomized phase 1 studies of single-blind, single-dose subcutaneous injection in healthy Japanese male participants

  Study 1 Study 2
FKB327
N = 65
RP
N = 65
FKB327
N = 65
RP
N = 65
Age Mean (SD) 28.1 (6.96) 28.2 (8.12) 26.5 (7.29) 27.1 (7.56)
BMI Mean (SD) 21.14 (1.581) 21.15 (1.549) 21.23 (1.905) 21.20 (1.695)
Weight Mean (SD) 61.92 (6.175) 62.56 (6.412) 61.74 (7.087) 62.09 (6.269)
< 65 kg (n [%]) 45 (69.2) 44 (67.7) 46 (70.8) 44 (67.7)
≥65 kg (n [%]) 20 (30.8) 21 (32.3) 19 (29.2) 21 (32.3)
  1. BMI Body mass index; RP Reference product; SD Standard deviation